CoinVoice has recently learned that the official information disclosure system of the Hong Kong Stock Exchange shows that on July 17, Huajian Medical (01931.HK) announced the official launch of the 'IVDNewCo Exchange' ecosystem plan, focusing on the RWA exchange ecosystem of high-tech assets in medical innovative drugs and the accompanying issuance of the IVDD stablecoin plan.
It is reported that the company is actively advancing the construction of an exchange ecosystem centered around high-tech assets in medical innovative drugs, named 'IVDNewCo Exchange', along with the issuance of a proprietary stablecoin (IVDDollar 'IVDD').
This strategy aims to promote the development of the traditional pharmaceutical industry by integrating Web3 technology (including RWA real-world asset tokenization, blockchain trading, and stablecoin mechanisms) to enhance the liquidity, financing efficiency, and accessibility of global medical innovative drug assets. [Original link]
